
research
Research suggesting GLP1 is a brain drug
Why has modern scientific opinion shifted to GLP1 being a brain drug rather than a gut drug? We dive into the critical research paper supporting the shift.
research
Why has modern scientific opinion shifted to GLP1 being a brain drug rather than a gut drug? We dive into the critical research paper supporting the shift.
usecase:kidney-disease
Tirzepatide (Mounjaro, Zepbound) shows results in weight loss and Hba1c reduction for southerners, critical to kidney disease treatment.
company:hikma
A new player enters the generic GLP1 market - Hikma Pharmaceuticals. As the second generic Liraglutide provider, accessibility of GLP1s has never been better.
category:news
HIMS leans into Liraglutide as a replacement for Semaglutide in the face of shortage rule changes. Is it good enough?
chemical:lixisenatide
Aldyxin' approaching 2025 patent expiry and what it could mean for new GLP1 drugs.
categeory:watercooler
New research that shows a benefit to appetite feedback control circuits via mathematical modeling, showing the benefits of using GLP1s.
Novo Nordisk's new CagriSema drug showed weight loss results that are *stunning*, but less than what Wall Street expected.
chemical:semaglutide
Semaglutide and Liraglutide continue to be researched and studied and produce positive results for weight loss and medical outcomes.
category:watercooler
We view the the reflection of public opinion on GLP1s and drugs like Ozempic, Mounjaro, and Zepbound through an unusual lens: Lizzo.
company:eli-lilly
Eli Lilly leans into the use of GLP1s for reducing addictive behavior, labeling them "anti-hedonics"
category:watercooler
We take another look at reports of what people are paying for GLP1s with/without insurance and everywhere in between.
category:factsheet
A list of FDA approved GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc), for easy reference.